GLOMERULAR INJURY IN CHRONIC MYELOMONOCYTIC LEUKEMIA

被引：31

作者：

MORSCHHAUSER, F ^{[1
]}

WATTEL, E ^{[1
]}

PAGNIEZ, D ^{[1
]}

LOVI, V ^{[1
]}

ROSE, C ^{[1
]}

BAUTERS, F ^{[1
]}

FENAUX, P ^{[1
]}

机构：

[1] CHU LILLE,SERV MALAD SANG,F-59037 LILLE,FRANCE

来源：

LEUKEMIA & LYMPHOMA | 1995年 / 18卷 / 5-6期

关键词：

MYELODYSPLASTIC SYNDROME; CHRONIC MYELOMONOCYTIC LEUKEMIA; CMML-GLOMERULOPATHY; NEPHROTIC SYNDROME; ACUTE RENAL FAILURE;

D O I：

10.3109/10428199509059648

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Among 825 cases of de novo myelodysplastic syndromes (MDS) diagnosed over a period of 13 years in our center, 4 had clinically significant glomerulopathy. All 4 fulfilled diagnostic criteria of chronic myelomonocytic leukemia (CMML), and could be classified in the low or intermediate risk groups according to two scoring systems. Presenting symptoms of renal involvement were edema in 3 cases and acute renal failure in the remaining patient. Three patients had the nephrotic syndrome. Renal biopsy (performed in 2 cases but considered as contraindicated in the other cases) showed AL amyloidosis on one case and extracapillary glomerulonephritis in the other case. The 4 patients were treated with V16 or hydroxyurea and two had renal improvement. Only one previous case of MDS associated with glomerulopathy has been reported before and also very probably had CMML. This, and the response of renal disease to chemotherapy in 2 of our patients suggests a possible relationship between the two disorders. More systematic investigation of glomerular function, in CMML, could possibly disclose a higher incidence of cases of glomerular injury in this type of MDS.

引用

页码：479 / 483

页数：5

共 17 条

[1]

Kramer P., Sizzo W., Twiss E.E., Nephrotic syndrome in Hodgkin disease, Neth, J. Med., 24, pp. 114-119, (1981)

[2]

Moulin B., Ronco P.M., Mougenot B., Francois A., Fillastre J.P., Mignon F., Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas, Kidney International, 42, pp. 127-135, (1992)

[3]

Gallo G., Buxbaum J., Monoclonal immunoglobulin deposition disease: immunopathologic aspects of renal involvement, The kidney in plasma cell dyscrasias, pp. 31-43, (1988)

[4]

Dosa S., Phillips T.M., Antonovych T.T., Segal A., Guha A., Thomson A.M., Acute myelomonocytic leukemia associated with nephrotic syndrome, Nephron, 34, pp. 125-129, (1983)

[5]

Sudholt B.A., Heironismus J.D., Chronic myelogenous leukemia with nephrotic syndrome, Arch. Intern. Med., 143, pp. 168-169, (1983)

[6]

Mufti G.J., A guide to risk assessment in the primary myelodysplastic syndrome, Hematol. Oncol. Clin, N. Am., 6, pp. 587-606

[7]

Paydas S., Tuncer I., Zorludemir S., Gonlusen G., A case with membranous glomerulonephritis and myelodysplastic syndrome, Nephron., 62, pp. 231-232, (1992)

[8]

Fenaux P., Beuscart R., Lai J.L., Jouet J.P., Bauters F., Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases, J. Clin. Onc., 6, pp. 1417-1424, (1988)

[9]

Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Gatton D., Gralnick H., Sultan C., Proposals for the classification of the myelodysplastic syndromes, Br. J. Haemutol., 51, pp. 189-199, (1982)

[10]

Worsley A., Oscier D., Stevens J., Hamblin T., Prognostic features of chronic myelomonocytic leukemia: a modified Bournemouth score gives the best prediction of survival, Br. J. Haematol., 68, pp. 17-21, (1988)

← 1 2 →